ライフサイエンスコーパス: TOF-MS

1 lity and repeatability of the developed EESI-TOF-MS were tested under complex dynamic and periodic ex

2 icability of two different platforms (LC-ESI-TOF MS and LC-ESI-IT MS) as powerful tools for the chara

3 lutive chromatographic method coupled to ESI-TOF MS (for initial characterisation purposes) and coupl

4 ion-time-of-flight mass spectrometry (CE-ESI-TOF-MS) has been developed.

5 d extraction (UAE) and the platform HPLC-ESI-TOF-MS was employed to characterize these components in

6 s were identified and quantified by HPLC-ESI-TOF-MS.

7 arp of this fruit was studied using HPLC/ESI-TOF-MS.

8 the basis of the additional dimension of ESI-TOF-MS.

9 zation time-of-flight mass spectrometry (ESI-TOF-MS) to derive the reaction mechanism and to obtain t

10 zation time-of-flight mass spectrometry (ESI-TOF-MS), thereby demonstrating the influence of differen

11 zation time-of flight mass spectrometry (ESI-TOF-MS).

12 fied limits and the brain concentrations for TOF MS (51.1 +/- 4.4 pmol/mg) and FTICR MS (56.9 +/- 6.0

13 ography time-of-flight mass spectrometry (GC-TOF MS) and liquid chromatography Orbitrap mass spectrom

14 ography time-of-flight mass spectrometry (GC-TOF MS) and liquid chromatography Orbitrap mass spectrom

15 entified a total of 327 metabolites using GC-TOF MS and LC-Orbitrap MS.

16 semi-quantified in maternal plasma using GC-TOF MS and LC-Orbitrap-MS.

17 ography-time-of-flight mass spectrometry (GC-TOF-MS) based metabolomics combined with partial least s

18 TD-GC-TOF-MS was used and a technique for the extraction of VO

19 trometry (GC-MS) and High Resolution GC x GC-TOF-MS (GC x GC HRT-4D).

20 th time-of-flight mass spectrometry (GC x GC-TOF-MS) was combined with conventional mono-dimensional

21 hy-time-of-flight mass spectrometry (GC x GC-TOF-MS), and their identity were confirmed by comparison

22 hy time-of-flight mass spectrometry (GC x GC-TOF-MS).

23 ography/time-of-flight mass spectrometry (GC/TOF-MS), here used to examine the S. cerevisiae metabolo

24 sample processing of data acquired by GCxGC-TOF MS for the identification of potentially novel persi

25 with time-of-flight mass spectrometry (GCxGC-TOF MS).

26 I) was evaluated as the ion source for GCxGC-TOF-MS measurements.

27 or Italian sparkling wines, by HS-SPME-GCxGC-TOF-MS and multivariate analysis.

28 dentification power of PI coupled with GCxGC-TOF-MS is the first report covering volatiles to low-vol

29 aselines, and GC(2)MS is able to align GCxGC/TOF-MS data sets acquired under different experimental c

30 However, GCxGC/TOF-MS data processing is currently limited to vendor so

31 the application of recent advances in GCxGC/TOF-MS, especially for metabolomics studies.

32 zed by a nontargeted approach based on GCxGC/TOF-MS.

33 aphy time-of-flight mass spectrometry (GCxGC/TOF-MS) is superior for chromatographic separation and p

34 GC(2)MS treats GCxGC/TOF-MS data as pictures and clusters the pixels as blobs

35 GC(2)MS then aligns the blobs of two GCxGC/TOF-MS data sets according to their distance and similar

36 ormance of GC(2)MS was evaluated using GCxGC/TOF-MS data sets of Angelica sinensis compounds acquired

37 An FM GC x GC-HR TOF MS method was developed for the untargeted and targe

38 olution time-of-flight mass spectrometer (HR TOF MS), under the challenging conditions of a flow-modu

39 The HR TOF MS instrument was operated at a spectral generation

40 LA-ICP-TOF-MS is employed to detect naturally occurring isotope

41 sma time-of-flight mass spectrometry (LA-ICP-TOF-MS).

42 plasma time-of-flight mass spectrometry (ICP-TOF-MS).

43 yed for the analysis of crude oils using IMS-TOF MS.

44 time-of-flight mass spectrometry (LAESI-IMS-TOF-MS) was used for the analysis of synthetic polymers

45 A sensitive and straightforward LC-IT-TOF-MS method was validated for the profiling and simult

46 on-trap time-of-flight mass spectrometer (IT-TOF-MS) for the separation and identification of constit

47 a time-of-flight mass spectrometer (UPLC-IT-TOF-MS) that allowed the characterization of the toxin p

48 0.27 mg/g of lyophilized coral using UPLC-IT-TOF-MS.

49 hat accurately detects the pure ions of a LC/TOF-MS profile to extract pure ion chromatograms and det

50 ography/time-of-flight mass spectrometry (LC/TOF-MS) ion signals in a complex biological sample remai

51 /+) degradation series in the respective LDI-TOF MS studies.

52 zation time-of-flight mass spectrometry (LDI-TOF MS) studies of the crystalline samples show intense

53 An in vitro MALDI TOF MS-based activity assay that detects ricin mediated

54 MALDI-TOF MS analysis of the suspension after density-based se

55 MALDI-TOF MS data combined with multivariate analysis, such as

56 MALDI-TOF MS demonstrated 80.1% (117/146) and 87.7% (128/146)

57 MALDI-TOF MS has shown great utility for rapidly identifying m

58 MALDI-TOF MS has the potential to expedite mold identification

59 MALDI-TOF MS is a valuable tool for the identification of thes

60 MALDI-TOF MS is becoming more commonplace for the genus- and/o

61 MALDI-TOF MS not only represents an innovative technology for

62 MALDI-TOF MS plus AMS intervention significantly reduced the o

63 MALDI-TOF MS significantly improved TAT for organism ID.

64 MALDI-TOF MS spectra of five F. nucleatum subspecies (animalis

65 MALDI-TOF MS was effective for the identification of mycobacte

66 MALDI-TOF MS with the modified SARAMIS database further correc

67 MALDI-TOF MS-based structural analysis of the mutant CWPS comb

68 grees C using a spectrophotometer) and MALDI-TOF MS (both the standard result output and by visual sp

69 standardized culture, extraction, and MALDI-TOF MS analysis, isolates were identified using score cu

70 value (NPV) of MALDI-TOF MS alone and MALDI-TOF MS coupled with UA were 86.6% versus 93.4% (chi(2) =

71 cation (CONV), (ii) manual plating and MALDI-TOF MS identification (MALDI), (iii) MALDI-TOF MS identi

72 Chemical cross-linking and MALDI-TOF MS mapped these same regions to the PhuS:HemO protei

73 ity and that the combination of UA and MALDI-TOF MS provided an accurate and rapid detection and iden

74 (1)H and (13)C NMR spectroscopy and MALDI-TOF MS showed a rigorously alternating sequence.

75 ant factors that must be considered as MALDI-TOF MS moves into applications beyond microbial identifi

76 (0.9%) isolates were misidentified by MALDI-TOF MS (including Aspergillus amoenus [n = 2] and Asperg

77 dilution of milks in water followed by MALDI-TOF MS analyses in the positive linear ion mode and usin

78 the substitution has been validated by MALDI-TOF MS analysis of the functionalized precursors and FT-

79 trometry (MS) types were identified by MALDI-TOF MS analysis, 53.5% isolates were MS4 and MS6, which

80 y testing of the samples identified by MALDI-TOF MS produced an overall categorical agreement of 99.2

81 ISA and VSSA isolates are separable by MALDI-TOF MS with SVM analysis.

82 ng bioconjugates were characterized by MALDI-TOF MS, differential scanning calorimetry (DSC), fluores

83 ISA, 21 hVISA, and 38 VSSA isolates by MALDI-TOF MS.

84 idin-3,5-O-diglycoside was verified by MALDI-TOF MS.

85 er species identification performed by MALDI-TOF MS.

86 mass spectrometry on tissue samples by MALDI-TOF MS.

87 ted from the capillary and analyzed by MALDI-TOF MS.

88 SDS-PAGE and protein identification by MALDI-TOF MS.

89 Here we report combined MALDI-TOF MS experiments, NMR analyses and quantum mechanical/

90 culturing can be avoided by conducting MALDI-TOF MS on individual bacterial cells.

91 targets and may be used for different MALDI-TOF MS applications.

92 This minireview explores MALDI-TOF MS-based typing, which has already been performed on

93 h 31, 2014, were directly compared for MALDI-TOF MS and conventional methodologies.

94 terial and yeast isolates prepared for MALDI-TOF MS identification can be repeatedly analyzed without

95 We conclude that guidelines for MALDI-TOF MS-based typing can be developed along the same line

96 ieve a trustworthy identification from MALDI-TOF MS data, a significant amount of biomass should be c

97 e containers and obtained identifiable MALDI-TOF MS collagen fingerprints, all indicative of the same

98 I-TOF MS identification (MALDI), (iii) MALDI-TOF MS identification and early phase implementation of

99 elevant Nocardia spp. and to implement MALDI-TOF MS libraries developed by single laboratories across

100 ed characteristic isotopic patterns in MALDI-TOF MS, and both a fragmentation product y1 ion correspo

101 With increasing MALDI-TOF MS use, CLs are well-advised to adhere strictly to s

102 implementation of TLA (TLA1), and (iv) MALDI-TOF MS identification and late phase implementation of T

103 ty of the Bruker Biotyper and Vitek MS MALDI-TOF MS systems and their in vitro diagnostic (IVD), rese

104 red, demonstrate the value of this new MALDI-TOF MS method as an analytical tool for the identificati

105 s have been characterized by (1)H NMR, MALDI-TOF MS, steady-state absorption and emission spectroscop

106 dia isolates, and NIH and OSU Nocardia MALDI-TOF MS libraries were distributed to three centers.

107 supplementation of the Bruker Nocardia MALDI-TOF MS library with both the OSU and NIH libraries incre

108 and negative predictive value (NPV) of MALDI-TOF MS alone and MALDI-TOF MS coupled with UA were 86.6%

109 is study was to evaluate the impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time

110 Use of MALDI-TOF MS and TLA individually and together results in sign

111 aluated the capacity of combination of MALDI-TOF MS and urine analysis (UA) for direct detection and

112 Our work highlights applications of MALDI-TOF MS beyond identification, focusing on mycobacterial

113 sifier, to bacterial classification of MALDI-TOF MS data.

114 The use of MALDI-TOF MS equated to a net savings of $69,108.61, or 87.8%,

115 highlights the superior performance of MALDI-TOF MS for bacterial identification.

116 ee sites, while specificity and NPV of MALDI-TOF MS for males were significantly higher than those fo

117 data describing the reproducibility of MALDI-TOF MS for microbial identification are scarce.

118 s review discusses the various uses of MALDI-TOF MS for the identification and susceptibility testing

119 his work, we report the specificity of MALDI-TOF MS for the identification of 162 Mycobacterium speci

120 monstrate the promising application of MALDI-TOF MS in evaluating the photodynamic effect of each com

121 in the databases and in the ability of MALDI-TOF MS to rapidly identify slowly growing mycobacteria a

122 specificity study, the performance of MALDI-TOF MS was directly compared with that of 16S rRNA gene

123 ither secondary biochemical testing or MALDI-TOF MS is of practical value.

124 peptides at other times of processing, MALDI-TOF MS was also employed as a fast and easier technique.

125 Recently, MALDI-TOF MS-based methodologies for bacteria detection/identi

126 xin test for the MALDI Biotyper Sirius MALDI-TOF MS system (Bruker Daltonics).

127 tion-time of flight mass spectrometry (MALDI-TOF MS) (e.g., Streptococcus oralis).

128 tion-time-of-flight mass spectrometry (MALDI-TOF MS) after enzymatic digestion of the polysaccharide

129 tion time of flight mass spectrometry (MALDI-TOF MS) analysis allowing in minutes the identification

130 tion-time of flight mass spectrometry (MALDI-TOF MS) and 16S rRNA gene sequencing.

131 tion-time of flight mass spectrometry (MALDI-TOF MS) and a fucK diagnostic assay.

132 tion-time of flight mass spectrometry (MALDI-TOF MS) and automated identification systems as well as

133 tion-time of flight mass spectrometry (MALDI-TOF MS) and BD Kiestra total laboratory automation (TLA)

134 tion-time of flight mass spectrometry (MALDI-TOF MS) and evaluated the capacity of combination of MAL

135 tion-time-of-flight mass spectrometry (MALDI-TOF MS) can be applied for the identification of pathoge

136 tion-time of flight mass spectrometry (MALDI-TOF MS) decreases the time to organism identification an

137 tion time-of-flight mass spectrometry (MALDI-TOF MS) experiments.

138 on - time-of-flight mass spectrometry (MALDI-TOF MS) fingerprinting of proteins was developed.

139 tion-time of flight mass spectrometry (MALDI-TOF MS) for group B streptococcus (GBS) identification,

140 tion-time of flight mass spectrometry (MALDI-TOF MS) for identification of Fusobacterium nucleatum su

141 tion-time of flight mass spectrometry (MALDI-TOF MS) for rapid organism identification and dedicating

142 tion-time of flight mass spectrometry (MALDI-TOF MS) for the identification of bacteria and yeasts is

143 tion time of flight mass spectrometry (MALDI-TOF MS) for the identification of Exophiala species.

144 tion-time of flight mass spectrometry (MALDI-TOF MS) for the identification of NTM isolated on RGM me

145 tion-time of flight mass spectrometry (MALDI-TOF MS) for yeast isolate identification, real-time PCR

146 tion-time of flight mass spectrometry (MALDI-TOF MS) has become the standard for routine bacterial sp

147 tion-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and accurate method for i

148 tion-time of flight mass spectrometry (MALDI-TOF MS) has recently been reported to be a reliable and

149 tion-time of flight mass spectrometry (MALDI-TOF MS) has reduced the time to identification of cultur

150 tion-time of flight mass spectrometry (MALDI-TOF MS) has revolutionized clinical microbiology for iso

151 tion-time of flight mass spectrometry (MALDI-TOF MS) identification and broth microdilution phenotypi

152 tion-time of flight mass spectrometry (MALDI-TOF MS) identification, and score interpretation, using

153 tion-time of flight mass spectrometry (MALDI-TOF MS) identified Staphylococcus lugdunensis to be a mo

154 tion-time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology has revolutionized spec

155 tion-time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial steward

156 tion-time of flight mass spectrometry (MALDI-TOF MS) in less than 15 min but is not optimized for the

157 tion time-of-flight mass spectrometry (MALDI-TOF MS) is described in this study.

158 tion time-of-flight mass spectrometry (MALDI-TOF MS) is frequently used for the characterization of c

159 tion-time of flight mass spectrometry (MALDI-TOF MS) or gene sequencing.

160 tion time-of-flight mass spectrometry (MALDI-TOF MS) plates, termed fast lipid analysis technique or

161 tion time-of-flight mass spectrometry (MALDI-TOF MS) platforms in the medical microbiological practic

162 tion-time of flight mass spectrometry (MALDI-TOF MS) sample preparation methods, including the direct

163 tion-time of flight mass spectrometry (MALDI-TOF MS) system was able to identify S. delphini to the s

164 tion time-of-flight mass spectrometry (MALDI-TOF MS) target plates printed by FDM technology using co

165 sorption/ionization mass spectrometry (MALDI-TOF MS) that allows quantification of pure or mixed dete

166 tion-time of flight mass spectrometry (MALDI-TOF MS) to detect pKpQIL_p019 (p019)-an approximately 11

167 tion time of flight mass spectrometry (MALDI-TOF MS) with only 1 muL of sample in a fast (less than 1

168 tion-time of flight mass spectrometry (MALDI-TOF MS) with Sepsityper processing (Bruker Daltonics, Bi

169 tion-time of flight mass spectrometry (MALDI-TOF MS), and 16S rRNA partial genome sequence analysis w

170 tion-time of flight mass spectrometry (MALDI-TOF MS), gas chromatography (GC), SDS-PAGE, Toll-like re

171 tion-time of flight mass spectrometry (MALDI-TOF MS), sequencing of eight genes in the GPL locus, and

172 tion-time of flight mass spectrometry (MALDI-TOF MS), suspicious isolates are now routinely identifie

173 tion-time of flight mass spectrometry (MALDI-TOF MS), which has a limited capacity to identify biolog

174 tion-time of flight mass spectrometry (MALDI-TOF MS)-based identifications of the flown and stationar

175 tion-time of flight mass spectrometry (MALDI-TOF MS).

176 tion-time of flight mass spectrometry (MALDI-TOF MS).

177 tion time-of-flight mass spectrometry (MALDI-TOF MS).

178 tion-time of flight mass spectrometry (MALDI-TOF MS).

179 tion-time of flight mass spectrometry (MALDI-TOF MS).

180 tion-time of flight mass spectrometry (MALDI-TOF MS).

181 tion time-of-flight mass spectrometry (MALDI-TOF MS).

182 tion Time-of-Flight Mass Spectrometry (MALDI-TOF MS).

183 me-of-flight tandem mass spectrometry (MALDI-TOF MS/MS), we now reveal that actually up to five fucos

184 In summary, MALDI-TOF MS allows the rapid and accurate identification of a

185 ere identified by biochemical testing, MALDI-TOF MS, and 16S rRNA sequence analysis (179 isolates; 2

186 MS intervention is more impactful than MALDI-TOF MS alone.

187 ynamic range and higher precision than MALDI-TOF MS, while still generating results in a similar time

188 Results suggest that MALDI-TOF MS and multivariate analysis are useful in determini

189 to the species level, suggesting that MALDI-TOF MS is the best option for distinguishing members of

190 In this study, we show that MALDI-TOF MS-based microbial identification is highly reproduc

191 r aerobic actinomycetes using both the MALDI-TOF MS manufacturer's supplied database(s) and a custom

192 142,532.69, versus $68,886.51 with the MALDI-TOF MS method, resulting in a laboratory savings of $73,

193 he beads are directly dispensed on the MALDI-TOF MS target enabling the identification and sensitive

194 Plasmid identification using this MALDI-TOF MS method was accomplished in as little as 10 min fr

195 ociated polysaccharides (CWPS) through MALDI-TOF MS and methylation analysis, we report on three such

196 stent with bactericidal rates and thus MALDI-TOF MS might be able to replace the LB agar colony to ev

197 AMS intervention included: real-time MALDI-TOF MS pharmacist notification and prospective AMS provi

198 cobacteria require extraction prior to MALDI-TOF MS analysis, previously published protocols have bee

199 Here we compared two MALDI-TOF MS instrumentation platforms and three databases: Br

200 d in a plastic bag, provided no useful MALDI-TOF MS spectra.

201 rowing organisms in BSCs and not using MALDI-TOF MS for identification until BTAs have been ruled out

202 ng to pre-TLA and post-TLA, both using MALDI-TOF MS for organism identification.

203 l microbiology laboratories to utilize MALDI-TOF MS for the rapid identification of clinically releva

204 he impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time, pharmacist-driven, antim

205 positive blood cultures identified via MALDI-TOF MS combined with prospective AMS intervention compar

206 ost of performing the bioMerieux Vitek MALDI-TOF MS with conventional microbiological methods to dete

207 gainst all Exophiala isolates in vitro MALDI-TOF MS successfully distinguished all 18 species and ide

208 ptibility testing might be useful when MALDI-TOF MS results in an organism identification, and it mig

209 d with RP HPLC, and characterized with MALDI-TOF MS and enzyme digestion essays.

210 hemical treatments in combination with MALDI-TOF MS and MS/MS.

211 WGS showed 99 and 93% concordance with MALDI-TOF MS at the genus and species levels, respectively.

212 al outcomes, rapid identification with MALDI-TOF MS combined with real-time AMS intervention is more

213 tion compared to a control cohort with MALDI-TOF MS identification without AMS intervention.

214 MALDI-TOF-MS analysis of N-linked glycans demonstrated reduced

215 MALDI-TOF-MS shows excellent potential for sensitive and rapid

216 Therefore, here we propose a MALDI-TOF-MS method for identification and relative quantifica

217 chniques such as RP-HPLC-UV, GFAAS and MALDI-TOF-MS allowed the identification of several proteins bo

218 thod for sialic acid stabilization and MALDI-TOF-MS analysis, to allow direct modification of impure

219 dies it was identified by SDS-PAGE and MALDI-TOF-MS that ZnPP formation takes place in myoglobin.

220 applied microchip electrophoresis and MALDI-TOF-MS-based glycomic procedures to 20 control serum sam

221 characterized by SDS-page, RP-HPLC and MALDI-TOF-MS.

222 nd E nterobacter spp. were analyzed by MALDI-TOF-MS in negative ion mode to obtain glycolipid mass sp

223 Biotyping by MALDI-TOF-MS will prove effective in situations wherein precis

224 e isolated, and structural analysis by MALDI-TOF-MS, GC-MS, and 2D NMR revealed that both were atypic

225 In contrast, MALDI-TOF-MS tracked as much (1)O2-induced RNA damage as RT-qP

226 hed an expeditious method that couples MALDI-TOF-MS with a simple dilution method to quantify curcumi

227 from kinetic investigations and DSC-, MALDI-TOF-MS-, (1)H NMR-studies of linear polymers prepared in

228 onisation properties and resolution in MALDI-TOF-MS, these phosphopeptides were identified as suitabl

229 -assisted laser desorption/ionization (MALDI-TOF-MS) for determination of Cu, Fe, Mn and Zn and ident

230 mbined with highly sensitive LC-MS/MS, MALDI-TOF-MS, and exoglycosidase treatments.

231 B and 1.2 x 10(5) J/m(2) UVA), neither MALDI-TOF-MS nor RT-qPCR detected significant decreases in the

232 Comparison of MALDI-TOF-MS spectra of all obtained extracts clearly indicate

233 5 h and automated data acquisition on MALDI-TOF-MS took on average less than 1 min per sample.

234 Following UV254 exposure, quantitative MALDI-TOF-MS detected significantly more RNA modifications tha

235 tion method to allow subclass-specific MALDI-TOF-MS analysis of tryptic IgG glycopeptides.

236 tion time-of-flight mass spectrometry (MALDI-TOF-MS) analysis of high abundance proteins is gaining p

237 tion Time of Flight Mass Spectrometry (MALDI-TOF-MS) biotyping to deliver rapid and accurate strain s

238 with time-of-flight mass spectrometry (MALDI-TOF-MS) has been used to analyse various molecules (incl

239 tion time-of-flight mass spectrometry (MALDI-TOF-MS) has successfully been used for the analysis of h

240 tion time-of-flight mass spectrometry (MALDI-TOF-MS) is a valuable tool for glycan characterization a

241 tion-time-of-flight-mass spectrometry (MALDI-TOF-MS) is presented.

242 tion time-of-flight mass spectrometry (MALDI-TOF-MS) is the preferred instrumental platform for finge

243 tion time-of-flight mass spectrometry (MALDI-TOF-MS) method and corresponding mathematic matrix to de

244 - time of flight - mass spectrometry (MALDI-TOF-MS).

245 tion time-of-flight mass spectrometry (MALDI-TOF-MS).

246 tion time-of-flight mass spectrometry (MALDI-TOF-MS).

247 ation with minimal side reactions: the MALDI-TOF-MS profiles obtained were in good agreement with hyd

248 cylglycerol) in complex mixtures using MALDI-TOF-MS with fractional factorial design (FFD) and Pareto

249 y RNA pulldown experiments followed by MALDI/TOF-MS analysis, we identified heterogeneous nuclear rib

250 s performed using 2-D-DIGE followed by MALDI/TOF-MS.

251 tireflection time-of-flight mass spectra (MR-TOF MS).

252 for wide m/z range applications, whereas MR-TOF MS can provide advantages in a "zoom-in" mode in whi

253 prising both conventional time-of-flight MS (TOF-MS) and nano-electromechanical systems-based MS (NEM

254 time-of-flight mass spectrometry (IR-MALDI-o-TOF MS) in combination with collision-induced dissociati

255 In this paper, we present results of a PI-TOF-MS study at the Advanced Light Source at Lawrence Be

256 ble to those with other synchrotron-based PI-TOF-MS reactors, and it is anticipated that this high pr

257 S research to include synchrotron sourced PI-TOF-MS required a radical reconception of the shock tube

258 ization time-of-flight mass spectrometry (PI-TOF-MS) is an important technique in combustion chemistr

259 action time-of-flight mass spectrometry (PTR-TOF-MS).

260 ncrease in pressure compared to standard PTR-TOF-MS.

261 is was performed using hybrid quadrupole (Q) TOF MS with an atmospheric pressure chemical ionization

262 pole-time-of-flight mass spectrometry (ESI-Q-TOF MS).

263 d to high resolution mass spectrometry (GC/Q-TOF MS).

264 ole time-of-flight mass spectrometry (HPLC-Q-TOF MS) with univariate and multivariate statistical ana

265 upole time-of-flight mass spectrometry (LC-Q-TOF MS) is described.

266 adrupole time-of-flight mass spectrometry (Q-TOF MS).

267 was done by UPLC(R)-QqQ-MS and UPLC(R)-ESI-Q-TOF-MS(E).

268 upole time-of-flight mass spectrometry (LC-Q-TOF-MS) was utilized to acquire metabolic profiles of mu

269 upole time-of-flight mass spectrometry (LC-Q-TOF-MS)-based global metabolomics analysis.

270 aphy-high-resolution mass spectrometry (LC-Q-TOF-MS).

271 AJICAP conjugation was established by SEC-Q-TOF-MS.

272 adrupole-time-of-flight mass spectrometry (Q-TOF-MS).

273 led rhizome was carried out utilizing UPLC-Q-TOF-MS(E), LC-QqQ-MS and GC-MS techniques and evaluated

274 ttle was investigated by FTICR-MS and UPLC-Q-TOF-MS.

275 This study aimed to identify by UPLC-PDA-Q/TOF-MS and quantify by UPLC-PDA phenolic compounds (26 f

276 time of flight-mass spectrometry (UPLC-PDA-Q/TOF-MS) method.

277 tored by UV-Vis spectroscopy and LC-ESI-(Qq)-TOF-MS-DAD, enabling the identification of some intermed

278 PD studies that the sensitivity of the REMPI-TOF-MS is comparable to commercial EI-Q-MS solutions and

279 al rituximab sample shows that online sLCxLC-TOF-MS can be used to rapidly characterize mAb samples,

280 med with a time-of-flight mass spectrometer (TOF-MS) to allow for a comprehensive evaluation of the o

281 resolution time-of-flight mass spectrometer (TOF-MS).

282 ionization time-of-flight mass spectrometry (TOF-MS) allows the detection of thousands of compounds.

283 apply LIAD time-of-flight mass spectrometry (TOF-MS) to the natural biochromophores chlorophyll, hemi

284 gh sensitivity and high mass accuracy of the TOF-MS revealed the presence of more than 70 glycans.

285 s, LC-MS-based quantification, and MALDI TOF-TOF MS analyses, we found that MaMmp10 catalyzes the met

286 imal plasmas were identified using MALDI-TOF-TOF MS.

287 time-of-flight mass spectrometry (MALDI-TOF/TOF MS) were used to assess the different protein expres

288 f flight tandem mass spectrometry (MALDI-TOF/TOF MS).

289 by fragmentation experiments using MALDI-TOF/TOF MS.

290 /time-of-flight mass spectrometry (MALDI-TOF/TOF-MS) for sequential identification of the peptide.

291 MR and DI-LC-MS/MS) and proteomic (MALDI-TOF/TOF-MS) platforms.

292 /time-of-flight mass spectrometry (MALDI-TOF/TOF-MS).

293 Extending the benefits of shock tube/TOF-MS research to include synchrotron sourced PI-TOF-MS

294 paper, the potential of Synapt G2-S (Q-TWIM-TOF MS) has been investigated for sensitive and specific

295 Quantitation by UHPLC/TOF-MS is accomplished by measuring the accurate mass of

296 aphy/time-of-flight mass spectrometry (UHPLC/TOF-MS), was used for the analysis of 60 pesticides in v

297 statically removed from the beam, and unlike TOF-MS, NEMS-MS can still measure masses.

298 Here, we used UPLC/TOF-MS to survey the lipidome in SOD1(G86R) mice, a mode

299 raction down to the low picogram range using TOF-MS.

300 S(+) radical scavenging assay and LC-MS with TOF-MS for compositional analysis of the most potent ant